BMT CTN Myeloma Intergroup Workshop on Minimal Residual Disease and Immune Profiling: Summary and Recommendations from the Organizing Committee

Holstein Sarah A.; Avet-Loiseau Nerve; Hahn Theresa; Ho Christine M.; Lohr Jens G.; Munshi Nikhil C.; Paiva Bruno; Pasquini Marcelo C.; Tario Joseph D. Jr.; Usmani Saad Z.; Wallace Paul K.; Weisel Katja; McCarthy Philip L.

首页> 外文期刊>Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation >BMT CTN Myeloma Intergroup Workshop on Minimal Residual Disease and Immune Profiling: Summary and Recommendations from the Organizing Committee

【24h】

BMT CTN Myeloma Intergroup Workshop on Minimal Residual Disease and Immune Profiling: Summary and Recommendations from the Organizing Committee

机译：BMT CTN骨髓瘤互动研讨会最少的残留疾病和免疫分析：组委会的摘要和建议

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

The Blood and Marrow Transplant Clinical Trials Network Myeloma Intergroup Workshop on Minimal Residual Disease and Immune Profiling was convened on December 1, 2016 at the American Society of Hematology meeting to discuss the emerging data and technologies for minimal residual disease assessment and immune profiling in myeloma. Particular emphasis was placed on developing strategies to incorporate these techniques into clinical trial design. This document reviews the literature, summarizes the topics discussed in the workshop, and provides recommendations for integration of these techniques into future clinical trial design. (C) 2017 American Society for Blood and Marrow Transplantation.

机译：2016年12月1日在美国血液学会会议上召开了血液和骨髓移植临床试验网络骨髓瘤杂交杂交研讨会，召开了美国血液学会议的美国社会，讨论了骨髓瘤中最少的残留疾病评估和免疫剖析的新兴数据和技术。特别强调发展策略，将这些技术纳入临床试验设计。本文件审查了文献，总结了研讨会讨论的主题，并为将这些技术集成到未来的临床试验设计中提供了建议。（c）2017年美国血液和骨髓移植协会。

著录项

来源
《Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation》 |2018年第4期|共8页
作者
Holstein Sarah A.; Avet-Loiseau Nerve; Hahn Theresa; Ho Christine M.; Lohr Jens G.; Munshi Nikhil C.; Paiva Bruno; Pasquini Marcelo C.; Tario Joseph D. Jr.; Usmani Saad Z.; Wallace Paul K.; Weisel Katja; McCarthy Philip L.;
展开▼
作者单位

Univ Nebraska Med Ctr Div Hematol &

Oncol Dept Internal Med Omaha NE 68142 USA;

Univ Canc Ctr Toulouse INSERM CRCT Toulouse France;

Roswell Pk Canc Inst Dept Med Blood &

Marrow Transplant Ctr Buffalo NY 14263 USA;

Roswell Pk Canc Inst Dept Med Blood &

Marrow Transplant Ctr Buffalo NY 14263 USA;

Dana Farber Canc Inst Dept Med Hematol Oncol Boston MA 02115 USA;

Dana Farber Canc Inst Dept Med Hematol Oncol Boston MA 02115 USA;

Clin Univ Navarra Ctr Invest Med Aplicadas Inst Invest Sanitaria Navarra Ctr Invest Biomed Red;

Med Coll Wisconsin Dept Med Hematol &

Oncol Milwaukee WI 53226 USA;

Roswell Pk Canc Inst Dept Med Blood &

Marrow Transplant Ctr Buffalo NY 14263 USA;

Levine Canc Inst Dept Hematol Oncol &

Blood Disorders Charlotte NC USA;

Roswell Pk Canc Inst Dept Med Blood &

Marrow Transplant Ctr Buffalo NY 14263 USA;

Univ Klinikum Tubingen Dept Hematol &

Oncol Tubingen Germany;

Roswell Pk Canc Inst Dept Med Blood &

Marrow Transplant Ctr Buffalo NY 14263 USA;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类治疗学;
关键词
Minimal residual disease; Immune profiling; Multiple myeloma; autologous stem cell transplant;

机译：最小的残留疾病;免疫分析;多发性骨髓瘤;自体干细胞移植;

相似文献

外文文献
中文文献
专利

1. BMT CTN Myeloma Intergroup Workshop on Minimal Residual Disease and Immune Profiling: Summary and Recommendations from the Organizing Committee [J] . Holstein Sarah A., Avet-Loiseau Nerve, Hahn Theresa, Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation . 2018,第4期

机译：BMT CTN骨髓瘤互动研讨会最少的残留疾病和免疫分析：组委会的摘要和建议
2. National Cancer Institute's First International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation: summary and recommendations from the organizing committee. [J] . Bishop MR, Alyea EP 3rd, Cairo MS, Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation . 2011,第4期

机译：美国国家癌症研究所首届同种异体造血干细胞移植后复发的生物学，预防和治疗国际研讨会：组委会的总结和建议。
3. Peripheral Immune Profile and Minimal Residual Disease (MRD) Burden Following Autologous Stem Cell Transplantation (ASCT) in Multiple Myeloma (MM) [J] . Foureau David, Zhang Qing, Cogdill Tammy D., Blood: The Journal of the American Society of Hematology . 2016,第22期

机译：多发性骨髓瘤（MM）自体干细胞移植（ASCT）后的外周免疫特性和最小残留疾病（MRD）负担
4. Minimal Residual Disease In Multiple Myeloma By LC-MS/MS Analysis Of Immunoglobulin Heavy And Light Chain CDR Tryptic Peptides [C] . Linda M. Benson, Angela Dispenzieri, David Murray, ASMS Conference on Mass Spectrometry and Allied Topics . 2016

机译：通过LC-MS / MS分析免疫球蛋白重链CDR胰蛋白酶蛋白的LC-MS / MS分析，在多发性骨髓瘤中最小的残留疾病
5. Targeted Capture and Sequencing of Immunoglobulin Rearrangements in Multiple Myeloma to Enable Detection of Minimal Residual Disease [D] . Chow, Signy. 2017

机译：在多发性骨髓瘤中针对性捕获和免疫球蛋白重排测序，以检测出最小的残留疾病
6. BMT CTN Myeloma Intergroup Workshop on Minimal Residual Disease and Immune Profiling: Summary and Recommendations from the Organizing Committee [O] . Sarah A. Holstein, Hervé Avet-Loiseau, Theresa Hahn, -1

机译：BMT CTN骨髓瘤最小残留病和免疫分析组间研讨会：组委会的总结和建议
7. BMT CTN Myeloma Intergroup Workshop on Minimal Residual Disease and Immune Profiling: Summary and Recommendations from the Organizing Committee [O] . Sarah A. Holstein, Hervé Avet-Loiseau, Theresa Hahn, 2018

机译：BMT CTN骨髓瘤互动研讨会最少的残留疾病和免疫分析：组委会的摘要和建议

BMT CTN Myeloma Intergroup Workshop on Minimal Residual Disease and Immune Profiling: Summary and Recommendations from the Organizing Committee

摘要

著录项

相似文献

相关主题

期刊订阅